TFF3通过诱导早期骨关节炎中滑膜巨噬细胞M1型极化促进软骨退变的作用及机制研究
批准号:
82102610
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
连成杰
依托单位:
学科分类:
骨、关节、软组织退行性病变
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
连成杰
中文摘要
骨关节炎(osteoarthritis, OA)中M1型滑膜巨噬细胞主导的滑膜炎是推动软骨退变的重要原因。早期OA即可发生上述滑膜炎改变,但是早期OA中诱导滑膜巨噬细胞M1型极化及相关炎症的原因和机制不明。我们预实验发现早期OA软骨细胞及关节液中TFF3表达上调,TFF3可显著促进滑膜巨噬细胞M1型极化,进一步发现CCR2受体和STAT1通路可能参与介导TFF3的调控作用。据此提出假说:早期OA中TFF3作用于CCR2受体激活STAT1通路,诱导滑膜巨噬细胞M1型极化及滑膜炎,进而促进软骨退变。本项目拟从分子、细胞、动物模型和患者标本等多层次展开研究:①明确TFF3通过诱导早期OA滑膜巨噬细胞M1型极化促进软骨退变的关键作用;②阐明TFF3促进滑膜巨噬细胞M1型极化的具体分子机制;③探索靶向抑制TFF3对于OA的治疗作用。此将为揭示OA发病机制、筛选新型治疗靶点提供理论依据。
英文摘要
M1-polarized synovial macrophages-mediated synovitis is one of the major risk factors of the degeneration of articular cartilage in osteoarthritis (OA), and is commonly found in early OA. However, in early OA, the factors inducing pro-inflammatory M1 polarization of synovial macrophages remain unknown. Our previous work showed that the expression of trefoil factor 3 (TFF3) was significantly elevated in chondrocytes and synovial fluid in early OA, and TFF3 could mediate M1 polarization of macrophages, during which CC Chemokine Receptor 2 (CCR2) and signal transducer and activator of transcription 1 (STAT1) may play a critical role. Thus, we hypothesized that in early OA, TFF3 causes M1 polarization of synovial macrophages through CCR2-STAT1 signaling, which subsequently promotes degeneration of chondrocytes. Further, we will reveal the biological function of TFF3 in promoting M1 polarization of synovial macrophages in early OA, and the detailed mechanisms underlying TFF3-induced M1 polarization of macrophages. Besides, we will study whether TFF3 could be a potent therapeutic target for OA. Thus, this study will provide a new insight in the pathogenesis of OA, and a novel strategy for the treatment of OA via targeting macrophages to regulate the inflammatory microenvironment.
骨关节炎(osteoarthritis, OA)中M1型滑膜巨噬细胞主导的滑膜炎症是推动软骨退变的重要原因。早期OA即可发生上述滑膜炎改变,但是早期OA中诱导滑膜巨噬细胞M1型极化及相关炎症的原因和机制不明。本项目原创性发现在早期OA关节液中TFF3表达水平显著升高,并且在整个病程均维持在高水平;进一步我们发现异常升高的TFF3来源于退变受损的软骨细胞,而它具有促进滑膜巨噬细胞M1型极化的功能,是介导OA早期滑膜炎症的关键;而TFF3诱导的M1型滑膜巨噬细胞进一步通过激活CCR2-STAT1通路,介导关节软骨退变和OA进展。以上研究结果提示一方面TFF3可以作为早期OA预警的生物标志物,另一方面TFF3及其下游信号通路可作为OA治疗的新型生物靶点。在该项目的支持下,我们还就Col2a1 p.Gly1170Ser突变、miR-601和miR-486-5p在股骨头缺血坏死中的作用和机制进行了探索,为该疾病的机制研究和治疗靶点筛选提供了新的理论依据;此外我们还研发了一种具有抗感染、免疫调控和促骨形成的多能复合支架,在感染性骨缺损等疾病中展示出一定的应用前景。基于以上研究成果,项目负责人以共同通讯作者发表原创性论著3篇,均为中科院2区,包括Advanced Healthcare Materials (IF: 10.0),Cell Mol Life Sci (IF: 6.2)和Stem Cells (IF: 4.0);申请国家发明专利5项(均已进入实审阶段);获中华医学科技奖三等奖1项。
国内基金
海外基金